Evidence map›Paper›PMID 32211439›Full record

ArticleERJ open research2020

12-year adherence to inhaled corticosteroids in adult-onset asthma.

Iida Vähätalo, Pinja Ilmarinen, Leena E Tuomisto, Minna Tommola, Onni Niemelä, Lauri Lehtimäki, Pentti Nieminen, Hannu Kankaanranta

Open access · goldAbstract read
In one paragraph

Article in ERJ open research, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
3.0field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 34 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Risk factors for asthma exacerbations.The journal of allergy and clinical immunology. Global · 2025
    Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Assessing adherence to inhaled therapies in asthma and the emergence of electronic monitoring devices.European respiratory review : an official journal of the European Respiratory Society · 2022
    Review
  15. Article
  16. Observational
  17. Article
  18. Observational
  19. Article
  20. Assessment of adherence to corticosteroids in asthma by drug monitoring or fractional exhaled nitric oxide: A literature review.Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology · 2021
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 1 country.

Iida VähätaloDept of Respiratory Medicine, Seinäjoki Central Hospital, Seinäjoki, Finland.ORCID https://orcid.org/0000-0003-0962-8446
Pinja IlmarinenDept of Respiratory Medicine, Seinäjoki Central Hospital, Seinäjoki, Finland.
Leena E TuomistoDept of Respiratory Medicine, Seinäjoki Central Hospital, Seinäjoki, Finland.ORCID https://orcid.org/0000-0001-6990-4508
Minna TommolaDept of Respiratory Medicine, Seinäjoki Central Hospital, Seinäjoki, Finland.ORCID https://orcid.org/0000-0003-4201-389X
Onni NiemeläDept of Laboratory Medicine, Seinäjoki Central Hospital, Seinäjoki, Finland.
Lauri LehtimäkiFaculty of Medicine and Health Technology, Tampere University, Tampere, Finland.
Pentti NieminenMedical Informatics and Statistics Research Group, University of Oulu, Oulu, Finland.
Hannu KankaanrantaDept of Respiratory Medicine, Seinäjoki Central Hospital, Seinäjoki, Finland.ORCID https://orcid.org/0000-0001-5258-0906
Seinäjoki University of Applied Sciences · FITampere University · FIUniversity of Oulu · FI

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Adherence to inhaled corticosteroids (ICS) has been suggested to be poor but long-term follow-ups are lacking. The objective of the present study was to assess adherence to ICS treatment in patients with adult-onset asthma during 12-year follow-up. A total of 181 patients with clinically confirmed, new-onset adult asthma were followed for 12 years as part of the Seinäjoki Adult Asthma Study. Adherence to ICS was assessed individually as the percentage of true dispensed ICS in micrograms per true prescribed daily ICS in micrograms over 12 years. Mean 12-year adherence to ICS was 69% (mean±sd dispensed 2.5±1.8 g and prescribed 3.6±1.5 g budesonide equivalent per patient for 12 years), annual adherence varying between 81% (year 1) and 67% (year 12). Patients with good 12-year adherence (≥80%) used oral corticosteroids more often, and had add-on drugs in use and asthma-related visits to healthcare more often. In addition, they showed less reversibility in forced expiratory volume in 1 s and had higher peripheral blood neutrophil counts. However, lung function decline was steeper in patients with poorer adherence (<80%) and this association remained in multiple linear regression analysis. No difference was found in symptom scores, blood eosinophil counts, exhaled nitric oxide or immunoglobulin E between the patients with different levels of adherence. In patients with adult-onset asthma, adherence to ICS was moderate. Poorer adherence (<80%) to ICS was associated with more rapid decline in lung function but was not associated to symptoms or markers of inflammatory endotypes.

Identifiers

PMID32211439
PMCPMC7086072
OpenAlexW3013939584

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.